{"issuance_frequency":"","notes_translated":{"fr":"La Loi sur les aliments et drogues et le Règlement sur les aliments et drogues régissent la vente et l'importation de drogues destinées aux essais cliniques sur des sujets humains au Canada. Ce document offre de l'orientation sur les obligations réglementaires en vertu de la Partie C, Section 5 du Règlement, Drogues destinées aux essais cliniques sur des sujets humains.","en":"The Food and Drugs Act and the Food and Drug Regulations govern the sale and importation of drugs for use in human clinical trials in Canada. This document provides guidance on the regulatory obligations pursuant to Part C, Division 5 of the Regulations, Drugs for Clinical Trials Involving Human Subjects."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"73ef69d8-47c1-45d4-ae5b-3e0b10ae44cd","metadata_created":"2021-06-01T18:01:50.695675","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-06-01T18:01:50.695681","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-06-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["document d'orientation","essai clinique","demandes d'essais cliniques","Loi sur les aliments et drogues","Règlement sur les aliments et drogues","essais cliniques sur l'homme","obligations réglementaires","du + H36gs pour les essais cliniques sur des sujets humains"],"en":["guidance document","clinical trial","clinical trial applications","Food and Drugs Act","Food and Drug Regulations","human clinical trials","regulatory obligations","du+H36gs for clinical trials involving human subjects"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice à l'intention des promoteurs d'essais cliniques : Demandes d'essais cliniques","en":"Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"73ef69d8-47c1-45d4-ae5b-3e0b10ae44cd","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c2e3cacd-fce4-4ecb-9be9-689c519fc51f","related_relationship":"","name_translated":{"fr":"Ligne directrice à l'intention des promoteurs d'essais cliniques : Demandes d'essais cliniques","en":"Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications","language":["en"],"created":"2021-06-01T18:01:50.777397","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/clinical-trial-sponsors-applications.html#a1","last_modified":null,"position":0,"revision_id":"53bc8b0a-3311-4d9c-9e96-f4eb1189b0e7","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"73ef69d8-47c1-45d4-ae5b-3e0b10ae44cd","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"cb36c757-785e-4e0c-8406-0460cad03008","related_relationship":"","name_translated":{"fr":"Ligne directrice à l'intention des promoteurs d'essais cliniques : Demandes d'essais cliniques","en":"Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications","language":["fr"],"created":"2021-06-01T18:01:50.777404","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/promoteurs-essais-cliniques-demandes.html#a1","last_modified":null,"position":1,"revision_id":"53bc8b0a-3311-4d9c-9e96-f4eb1189b0e7","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2016-06-29 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"73ef69d8-47c1-45d4-ae5b-3e0b10ae44cd","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Food and Drugs Act and the Food and Drug Regulations govern the sale and importation of drugs for use in human clinical trials in Canada. This document provides guidance on the regulatory obligations pursuant to Part C, Division 5 of the Regulations, Drugs for Clinical Trials Involving Human Subjects.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications","revision_id":"53bc8b0a-3311-4d9c-9e96-f4eb1189b0e7"}